Polyplus-transfection® is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bio-production and therapeutics.

Headquartered near Strasbourg (France), Polyplus-transfection® was founded in 2001 as a spin-off from the Genetic Chemistry Laboratory in the Faculty of Pharmacy, University of Strasbourg. The company has a global reputation in its niche market following the pioneering role of its main founder, Prof. Jean-Paul Behr, in the development of a polymer based reagent, PEI (Polyethylenimine), for use in transfection.

Polyplus-transfection® is ISO 9001-certified since 2002 and supplies a wide range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus-transfection® reagents are used by research, clinical and commercial stage clients globally.

www.polyplus-transfection.com

INVESTMENT DATE
2016

ACTIVITY
Life Sciences

TRANSACTION TYPE
Buy-Out

GROWTH THEME
Innovation and International Market Penetration

LOCATION
France